Sana Biotechnology, Inc

Contributing Author

Recent Articles by Sana Biotechnology, Inc

May-27	Sana Biotechnology to Present at June 2026 Investor Conferences SANA GlobeNewswire
May-15	Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility SANA GlobeNewswire
May-12	Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs SANA -8.43% GlobeNewswire
May-11	Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates SANA GlobeNewswire
May-05	Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference SANA GlobeNewswire
Apr-27	Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting SANA GlobeNewswire
Apr-13	Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451 SANA +8.41% SANA GlobeNewswire
Mar-13	Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression SANA +8.74% GlobeNewswire
Mar-03	Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates SANA -5.30% GlobeNewswire
Feb-23	Sana Biotechnology to Present at March 2026 Investor Conferences SANA GlobeNewswire
Feb-17	Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer SANA GlobeNewswire
Jan-07	Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference SANA +8.49% GlobeNewswire
Dec-08	Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform SANA -9.75% GlobeNewswire
Nov-24	Sana Biotechnology to Present at December 2025 Investor Conferences SANA +7.60% GlobeNewswire
Nov-06	Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates SANA GlobeNewswire
Nov-04	Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit SANA -9.19% GlobeNewswire
Aug-26	Sana Biotechnology to Present at September 2025 Investor Conferences SANA GlobeNewswire
Aug-20	Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares SANA GlobeNewswire
Aug-11	Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates SANA +6.51% SANA GlobeNewswire
Aug-06	Sana Biotechnology Announces Pricing of Public Offering SANA -30.12% GlobeNewswire
Aug-06	Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants SANA -30.12% SANA GlobeNewswire
Aug-04	Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes SANA +8.18% GlobeNewswire
Jun-23	Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression SANA GlobeNewswire
Jun-09	Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions SANA GlobeNewswire
May-28	Sana Biotechnology to Present at June 2025 Investor Conferences SANA +12.50% GlobeNewswire
May-12	Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference SANA -10.25% SANA +9.89% GlobeNewswire
May-08	Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates SANA +6.47% GlobeNewswire

Sana Biotechnology, Inc

Recent Articles by Sana Biotechnology, Inc

Upgrade your Finviz experience